Real projects. Real insights. Real impact on India’s trade landscape.
Mapped India’s pharmaceutical exports across 45 countries, identifying growth corridors in Africa and Southeast Asia. Analyzed 8 quarters of data showing a 12% CAGR in specialty formulations, with recommendations for API suppliers on high-demand markets.
Built a quarterly monitoring dashboard for a financial services firm tracking India’s current account trends, invisible earnings from IT services, and capital account volatility. Included stress-testing scenarios for rupee depreciation impact.
Evaluated the India-UAE CEPA agreement impact on 6 key sectors including gems, textiles, and chemicals. Quantified tariff savings for 220+ product lines and identified supply chain opportunities. Results presented to 3 industry chambers.
Identified $2.8B annual import opportunity in semiconductor assembly and electronic components. Mapped 34 product categories with feasibility assessments for domestic production, targeting 35% import substitution over 5 years.
Let’s work together to turn trade data into actionable strategy.
Start a conversation